Clinical Trial Update: Three-month, Single-center Study to Identify Biomarkers/Response to Xolair Therapy in Chronic Idiopathic Urticaria [NA]

View source ↗

Summary

This completed single-center trial investigated biomarkers and response to omalizumab (Xolair) therapy in chronic idiopathic urticaria. The study status is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Urticaria

Drugs mentioned

• Xolair (omalizumab)

Snippet

Sponsor: Asthma Inc Clinical Research Center | Conditions: Chronic Idiopathic Urticaria | NA | Status: COMPLETED